10-112950801-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_001367943.1(TCF7L2):c.45C>T(p.Asn15=) variant causes a synonymous change. The variant allele was found at a frequency of 0.00198 in 1,593,186 control chromosomes in the GnomAD database, including 54 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.010 ( 30 hom., cov: 29)
Exomes 𝑓: 0.0011 ( 24 hom. )
Consequence
TCF7L2
NM_001367943.1 synonymous
NM_001367943.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.30
Genes affected
TCF7L2 (HGNC:11641): (transcription factor 7 like 2) This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.24).
BP6
Variant 10-112950801-C-T is Benign according to our data. Variant chr10-112950801-C-T is described in ClinVar as [Benign]. Clinvar id is 780893.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0104 (1582/151888) while in subpopulation AFR AF= 0.0357 (1478/41392). AF 95% confidence interval is 0.0342. There are 30 homozygotes in gnomad4. There are 733 alleles in male gnomad4 subpopulation. Median coverage is 29. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1582 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TCF7L2 | NM_001367943.1 | c.45C>T | p.Asn15= | synonymous_variant | 1/15 | ENST00000355995.9 | |
LOC124902502 | XR_007062291.1 | n.772G>A | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TCF7L2 | ENST00000355995.9 | c.45C>T | p.Asn15= | synonymous_variant | 1/15 | 1 | NM_001367943.1 | ||
ENST00000369391.3 | n.305G>A | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0104 AC: 1580AN: 151772Hom.: 30 Cov.: 29
GnomAD3 genomes
AF:
AC:
1580
AN:
151772
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00257 AC: 565AN: 219846Hom.: 11 AF XY: 0.00195 AC XY: 231AN XY: 118430
GnomAD3 exomes
AF:
AC:
565
AN:
219846
Hom.:
AF XY:
AC XY:
231
AN XY:
118430
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00110 AC: 1579AN: 1441298Hom.: 24 Cov.: 32 AF XY: 0.000919 AC XY: 657AN XY: 714734
GnomAD4 exome
AF:
AC:
1579
AN:
1441298
Hom.:
Cov.:
32
AF XY:
AC XY:
657
AN XY:
714734
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0104 AC: 1582AN: 151888Hom.: 30 Cov.: 29 AF XY: 0.00988 AC XY: 733AN XY: 74210
GnomAD4 genome
AF:
AC:
1582
AN:
151888
Hom.:
Cov.:
29
AF XY:
AC XY:
733
AN XY:
74210
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at